Events & Presentations

Investors

Events & Presentations

Upcoming Events
More events are coming soon.
Archived Events
Date Event Details
Dec 6 - Dec 10, 2015 12:00 AM EST
HEP DART 2015
Wailea, Hawaii

December 8, 6:40 p.m. HST – Bruce Given, M.D., Arrowhead chief operating officer, will deliver an oral presentation titled, “New insights on HBV biology from the ARC-520 development program

December 8, 4:00 - 5:30 p.m. HST – Christine Wooddell, Ph.D., Arrowhead group leader will deliver a poster presentation titled, “Sustained reduction in HBsAg, HBV DNA and HBeAg seroconversion in a chronically HBV-infected chimpanzee treated with nucleoside analog/ARC-520 combination therapy

Dec 1 - Dec 2, 2015 12:00 AM EST
Piper Jaffray 27th Annual Healthcare Conference
New York

December 2, 3:00 p.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray

Nov 18 - Nov 19, 2015 12:00 AM EST
Jefferies Autumn 2015 Global Healthcare Conference
London, UK

November 19, 2:40 p.m. GMT – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview

Nov 17, 2015 8:00 AM PST
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 17, 8:00 a.m. - 12:00 p.m. PST - Christine Wooddell, Ph.D., group leader will deliver a poster presentation titled, "Monthly dosing of ARC-520 in chronically hepatitis B virus infected chimpanzees produces rapid, deep and durable reductions in circulating viral antigens"

Nov 16, 2015 6:30 PM PST
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 6:30 p.m. PST - Arrowhead management will host an Analyst and Investor Reception to discuss ARC-520 and key data being presented at the conference

Nov 16, 2015 8:00 AM PST
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 8:00 a.m. - 5:30 p.m. PST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, will deliver a late-breaking poster presentation titled, “ARC-520 produces deep and durable knockdown of viral antigens and DNA in a phase II study in patients with chronic hepatitis B

Nov 15, 2015 3:15 PM PST
The Liver Meeting 2015®, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
San Francisco

November 15, 3:15 p.m. PST - Christine Wooddell, Ph.D., group leader will deliver an oral presentation titled, "Reductions in cccDNA under NUC and ARC-520 therapy in chimpanzees with chronic hepatitis B virus infection implicate integrated DNA in maintaining circulating HBsAg"

Oct 14, 2015 3:30 PM CEST
11th Annual Meeting of the Oligonucleotide Therapeutics Society
Netherlands
Bruce Given, M.D., Chief Operating Officer
Oct 7, 2015 5:00 PM CEST
2015 International Meeting on Molecular Biology of Hepatitis B
Germany
Christine Wooddell, Ph.D., Group Leader
Oct 6, 2015 2:45 PM EDT
Partnerships in Drug Delivery
Boston
David Rozema, Ph.D., Vice President, Chemistry